Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study

Sci Bull (Beijing). 2022 Aug 15;67(15):1556-1561. doi: 10.1016/j.scib.2022.06.025. Epub 2022 Jun 30.

Hao Lin¹, Xueyuan Liu^{1

2

3}, Heqiang Sun⁴, Jie Zhang¹, Shaobo Dong⁵, Maoshun Liu^{1

6}, Lei Li^{1

6}, Jinmin Tian^{1

7}, Yaxin Guo¹, Jinxian Gan^{1

8}, Zhangfu Chen^{1

2}, Xin Wang^{1

2}, Ying Lin^{1

2}, Danni Zhang¹, Yaning Liu¹, Xiaoshan Zhang¹, Peipei Liu^{1

9}, Ke Xu¹, Xiangtian Zhou⁷, Hao Liang⁸, George F Gao^{1

3

9}, William J Liu^{1

9}, Guizhen Wu^{1

9}

¹ National Health Commission Key Laboratory of Biosafety, Research Unit of Adaptive Evolution and Control of Emerging Viruses, Chinese Academy of Medical Sciences, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
² Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
³ CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
⁴ Department of Laboratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
⁵ Macheng Center for Disease Control and Prevention, Huanggang 438300, China.
⁶ College of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
⁷ School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, China.
⁸ Collaborative Innovation Center of Regenerative Medicine and Medical Biological Resources Development and Application, Guangxi Medical University, Nanning 530021, China.
⁹ Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

No abstract available